Strategies and Challenges to Develop Therapeutic Candidates against COVID-19 Pandemic
Rohit Bhatia1, *, Subrahmanya S Ganti1, Raj Kumar Narang2, Ravindra Kumar Rawal3
1 Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab-142001, India
2 Department of Pharmaceutics, ISF College of Pharmacy, Ferozepur G.T. Road, Moga-142 001, Punjab, India
3 Department of Chemistry, Maharishi Markandeshwar (Deemed to be University), Mullana-133207, Haryana, India
Abstract
Keywords:
Pandemic
,
COVID-19
,
Therapeutic candidates
,
Epidemics
,
Respiratory syndrome
,
SARS-CoV
.
Article Information
Article History:
Received Date: 07/5/2020
Revision Received Date: 07/7/2020
Acceptance Date: 08/8/2020
Electronic publication date: 20/10/2020
Collection year: 2020
© 2020 Bhatia et al.
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at:
https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
* Address correspondence to this author at the Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab-142001, India; Tel: 8628885561; E-mail: bhatiarohit5678@gmail.com
Open Peer Review Details |
Manuscript submitted on 07-5-2020 |
Original Manuscript |
Strategies and Challenges to Develop Therapeutic Candidates against COVID-19 Pandemic |